The study shows that the SARS-CoV-2 spike protein remains in the ... Other mRNA vaccines or vaccine types, such as vector- or ...

The viral vector derived from adenovirus, which infects cells readily but does not cause disease onset, serves as a carrier that delivers genetic materials that code for the SARS-CoV-2 spike ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

Researchers have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 ...

In the case of AZD1222, this protein is the spike protein of SARS-CoV-2, the virus that causes COVID-19. In 2012, researchers at the University of Oxford created ChAdOx1, a virus vector vaccine ...

SARS originated in Guangdong province , southern China and by the time it had been brought … Severe Acute Respiratory Syndrome (SARS) is a disease that first appeared in humans in November 2002.